Literature DB >> 9427056

Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates.

T F Schwarz1, H Nsanze, A M Ameen.   

Abstract

Crimean-Congo haemorrhagic fever (C-CHF) re-emerged recently in the United Arab Emirates. The clinical outcome of 11 cases of viral haemorrhagic fever patients admitted to hospital between June 1994 and January 1995 is described. Four cases were laboratory confirmed retrospectively as C-CHF, the other patients were diagnosed likely to have the same disease on epidemiological and clinical grounds. In 72.7% of the patients, infection was fatal. Symptoms started 3.5 days before hospitalization. On admission, 81.8% of patients had high fever, 45.5% were vomiting, 63.6% had diarrhoea, 45.5% had haemorrhagic signs, and 18.2% had throat pain. Fatalities occurred 6.8 days after admission. Survivors were hospitalized for 9.3 days. Nosocomial transmission was not observed.

Entities:  

Mesh:

Year:  1997        PMID: 9427056     DOI: 10.1007/BF01740819

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  17 in total

Review 1.  The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa.

Authors:  H Hoogstraal
Journal:  J Med Entomol       Date:  1979-05-22       Impact factor: 2.278

2.  Assessment of arthropod vectors of infectious diseases in areas of U.S. troop deployment in the Persian Gulf.

Authors:  S E Cope; G W Schultz; A L Richards; H M Savage; G C Smith; C J Mitchell; D J Fryauff; J M Conlon; J A Corneil; K C Hyams
Journal:  Am J Trop Med Hyg       Date:  1996-01       Impact factor: 2.345

3.  Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China.

Authors:  Y C Yen; L X Kong; L Lee; Y Q Zhang; F Li; B J Cai; S Y Gao
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

4.  Crimean-Congo haemorrhagic fever in Oman.

Authors:  E M Scrimgeour; A Zaki; F R Mehta; A K Abraham; S Al-Busaidy; H El-Khatim; S F Al-Rawas; A M Kamal; A J Mohammed
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 May-Jun       Impact factor: 2.184

5.  Serodiagnosis of Crimean-Congo haemorrhagic fever.

Authors:  F J Burt; P A Leman; J C Abbott; R Swanepoel
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

6.  The clinical pathology of Crimean-Congo hemorrhagic fever.

Authors:  R Swanepoel; D E Gill; A J Shepherd; P A Leman; J H Mynhardt; S Harvey
Journal:  Rev Infect Dis       Date:  1989 May-Jun

7.  Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital.

Authors:  M N Suleiman; J M Muscat-Baron; J R Harries; A G Satti; G S Platt; E T Bowen; D I Simpson
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

8.  A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis.

Authors:  J R Joubert; J B King; D J Rossouw; R Cooper
Journal:  S Afr Med J       Date:  1985-11-09

9.  Crimean Congo-haemorrhagic fever treated with oral ribavirin.

Authors:  S P Fisher-Hoch; J A Khan; S Rehman; S Mirza; M Khurshid; J B McCormick
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

10.  Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection.

Authors:  G H Tignor; C A Hanham
Journal:  Antiviral Res       Date:  1993-12       Impact factor: 5.970

View more
  24 in total

1.  Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus.

Authors:  Roman Wölfel; Janusz T Paweska; Nadine Petersen; Antoinette A Grobbelaar; Patricia A Leman; Roger Hewson; Marie-Claude Georges-Courbot; Anna Papa; Volker Heiser; Marcus Panning; Stephan Günther; Christian Drosten
Journal:  J Clin Microbiol       Date:  2009-02-18       Impact factor: 5.948

2.  Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

Authors:  S M Ghiasi; A H Salmanian; S Chinikar; S Zakeri
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

Review 3.  An Emerging Biothreat: Crimean-Congo Hemorrhagic Fever Virus in Southern and Western Asia.

Authors:  Paul W Blair; Jens H Kuhn; David B Pecor; Dmitry A Apanaskevich; Mark G Kortepeter; Anthony P Cardile; Aileen Polanco Ramos; Maryam Keshtkar-Jahromi
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

4.  Rescue of Infectious Recombinant Hazara Nairovirus from cDNA Reveals the Nucleocapsid Protein DQVD Caspase Cleavage Motif Performs an Essential Role other than Cleavage.

Authors:  J Fuller; R A Surtees; G S Slack; J Mankouri; R Hewson; J N Barr
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

5.  Short report: Diagnostic testing for hemorrhagic fevers in Pakistan: 2007-2013.

Authors:  Zahra Hasan; Barry Atkinson; Bushra Jamil; Azra Samreen; Lamia Altaf; Roger Hewson
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

6.  Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species.

Authors:  M K Deaton; J V Dzimianski; C M Daczkowski; G K Whitney; N J Mank; M M Parham; E Bergeron; S D Pegan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

7.  A new strain of Crimean-Congo hemorrhagic fever virus isolated from Xinjiang, China.

Authors:  Rong Guo; Shu Shen; Yanfang Zhang; Junming Shi; Zhengyuan Su; Dan Liu; Jinliang Liu; Juan Yang; Qiguo Wang; Zhihong Hu; Yujiang Zhang; Fei Deng
Journal:  Virol Sin       Date:  2017-02-27       Impact factor: 4.327

8.  Expression, purification and crystallization of the Crimean-Congo haemorrhagic fever virus nucleocapsid protein.

Authors:  S D Carter; J N Barr; T A Edwards
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-04-21

9.  Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.

Authors:  A Duran; A Küçükbayrak; T Ocak; N I Hakyemez; T Taþ; M Karadađ; Z F Mengelođlu
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

Review 10.  Emerging Tick-Borne Diseases.

Authors:  Susan Madison-Antenucci; Laura D Kramer; Linda L Gebhardt; Elizabeth Kauffman
Journal:  Clin Microbiol Rev       Date:  2020-01-02       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.